NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Biomatics Capital Partners

Biomatics Capital Partners

Seattle, Washingtonbiomaticscapital.com

Overview

Biomatics Capital is a venture capital firm focused on transforming the future of healthcare through strategic investments in genomics and digital data. The firm aims to develop superior therapeutics, diagnostics, and delivery models that lead to a value-based healthcare system with lower costs and better patient outcomes. The firm seeks to invest in companies operating in the healthcare, technology and life science sectors. Biomatics Capital partners with entrepreneurs to support groundbreaking technologies and create exceptional value through a network of experts.

Year Founded

2016

Portfolio Companies

14

Investments

Biomatics Capital Partners investments
CompanyDateStageLead
EncodiaJan 2021Series C-
VerveJan 2021Series B-
VerveJun 2020Series A Extension-
Variant BioMay 2020Series ACo-investor
OmniomeJan 2020Series CCo-investor

Key People

Julie Sunderland

Managing Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersSeattle, Washington
Year Founded2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.